ÂÜÀòÂÒÂ×

Sarah Mullen has a extensive work experience in the healthcare industry. Sarah worked at HeartFlow, Inc since 2017, starting as a Director, Clinical Research and progressing to VP Clinical, with an interim position in Quality and Regulatory. Before that, they held a Director position at Carbylan Therapeutics and a Senior Manager role at Carbylan. Sarah also served as a Clinical Manager at Spiracur, Inc. and held various research-related roles at Spiracur, ev3, FoxHollow Division, FoxHollow Technologies, Elan Pharmaceuticals, The Cardiovascular Institute, and BioScience Incubator.

Sarah Mullen attended San Jose State University from 2003 to 2005, where they pursued a degree in Biotechnology and obtained their MBT. Prior to that, they attended Colorado College from 1999 to 2002, earning their Bachelor's degree in Neuroscience. Additionally, Sarah attended LGHS, although specific dates and degrees are not provided.